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Formål  Maintenance of healthy bones is highly dependent on constant renewal of the bones 
through bone remodelling – a tightly regulated process involving coordinated bone 
resorption and formation. Classical histomorphometry generally focuses on these two events 
whereas only little attention is given to the intermediate phase, known as the reversal phase. 
This phase might actually play an important role in the preparation of resorbed surfaces for 
the subsequent formation and might thus be essential for coordinating resorption and 
formation. Uncoordinated activities might result in bone loss as observed in Glucocorticoid 
(GC)-treatment. GCs are known to exert negative effects on especially bone formation 
including direct effects on osteoblastic cells. However, to understand the precise mechanism 
behind the negative effects on bone further investigation is still needed. In this study special 
attention was given to the reversal phase to elucidate whether remodelling is affected at the 
reversal level in GC-treated patients. 
Metode  Masson Trichrome-stained sections of cancellous bone from 15 GC-treated patients and 10 
sex- and age-matched controls were assessed for conventional parameters including the 
proportion of eroded (ES/BS), osteoid (OS/BS), osteoclast (Oc.S/BS), and osteoblast (Ob.S/BS) 
to total bone surface were assessed. Additionally, special attention was here given to the 
reversal surfaces (Rv.S) where a discrimination was made between active Rv.S (Ac.Rv.S) 
defined as Rv.S flanking OC or OS and arrested Rv.S (Ar.Rv.S) defined as Rv.S away from OC 
or OS. 
Resultater  No difference in ES/BS, Oc.S/BS, or OS/BS was observed between controls and GC-treated 
patients. Similarly Rv.S/BS was also unaffected. Interestingly, when distinguishing between 
Ac.Rv.S/BS and Ar.RvS/BS a clear difference was observed. The extent of Ac.Rv.S/BS was at 
the same level in the two groups (6.6% in control vs. 5.9% in GC-treated patients) whereas 
the extent of Ar.Rv.S/BS was significantly increased (1.1% vs. 4.9%). Additionally, GC-treated 
patients showed significantly less Ob.S/BS (21.6% vs. 15.3%). These results indicate that, in 
addition to bone forming osteoblast, “reversal cells”, which are commonly considered as 
preosteoblast, also are negatively affected by GCs. Reversal cells might be prevented in their 
differentiation into bone forming cells whereby the transition from resorption to formation 
is aborted thus resulting in an accumulation of Ar.Rv.S. 
Konklusion  Arrest of Rv.S seems to be a critical mechanism involved in GC-induced bone loss. 
  
